Next Article in Journal
Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan
Next Article in Special Issue
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments
Previous Article in Journal
Influence of the Efavirenz Micronization on Tableting and Dissolution
Review

Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation

1
Institute of Imaging Science, Vanderbilt University, Nashville, TN, 37232-2310, USA
2
Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN 37232, USA
3
Program in Chemical and Physical Biology, Vanderbilt University, Nashville, TN 37232, USA
4
Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235-1826, USA
5
Department of Physics and Astronomy, Vanderbilt University, Nashville, TN 37235, USA
6
Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232-6838, USA
7
Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA
*
Author to whom correspondence should be addressed.
Pharmaceutics 2012, 4(3), 442-478; https://doi.org/10.3390/pharmaceutics4030442
Received: 20 July 2012 / Revised: 1 September 2012 / Accepted: 10 September 2012 / Published: 19 September 2012
(This article belongs to the Special Issue DCE-MRI in Preclinical Imaging)
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) consists of the continuous acquisition of images before, during, and after the injection of a contrast agent. DCE-MRI allows for noninvasive evaluation of tumor parameters related to vascular perfusion and permeability and tissue volume fractions, and is frequently employed in both preclinical and clinical investigations. However, the experimental and analytical subtleties of the technique are not frequently discussed in the literature, nor are its relationships to other commonly used quantitative imaging techniques. This review aims to provide practical information on the development, implementation, and validation of a DCE-MRI study in the context of a preclinical study (though we do frequently refer to clinical studies that are related to these topics). View Full-Text
Keywords: DCE-MRI; mouse; cancer; diffusion; FLT; FDG; FMISO DCE-MRI; mouse; cancer; diffusion; FLT; FDG; FMISO
Show Figures

Figure 1

MDPI and ACS Style

Barnes, S.L.; Whisenant, J.G.; Loveless, M.E.; Yankeelov, T.E. Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation. Pharmaceutics 2012, 4, 442-478. https://doi.org/10.3390/pharmaceutics4030442

AMA Style

Barnes SL, Whisenant JG, Loveless ME, Yankeelov TE. Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation. Pharmaceutics. 2012; 4(3):442-478. https://doi.org/10.3390/pharmaceutics4030442

Chicago/Turabian Style

Barnes, Stephanie L.; Whisenant, Jennifer G.; Loveless, Mary E.; Yankeelov, Thomas E. 2012. "Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation" Pharmaceutics 4, no. 3: 442-478. https://doi.org/10.3390/pharmaceutics4030442

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop